5 Best Beaten Down Stocks To Buy Right Now

Page 5 of 5

1. Biogen Inc. (NASDAQ:BIIB)

Number of Hedge Fund Investors In Q4 2023: 51

52-Week Range: $217.53 – $319.76

Current Share Price: $219.08

Biogen Inc. (NASDAQ:BIIB) is an American healthcare company that develops treatments for nervous system disorders and associated diseases. After its fourth quarter revenue of $2.39 billion missed analyst estimates of $2.46 billion, Baird reduced the share price target to $316 from $333 and kept an Outperform rating as it shared that the firm could pursue acquisitions to make up for the revenue shortfall.

51 out of the 933 hedge funds tracked by Insider Monkey had bought and owned the firm’s shares as of Q4 2023 end. Biogen Inc. (NASDAQ:BIIB)’s largest hedge fund investor is Samuel Isaly’s OrbiMed Advisors courtesy of its $214 million stake.

Follow Biogen Inc. (NASDAQ:BIIB)

Disclosure: None. You can also take a look at 12 Best Blue Chip Stocks To Invest In According to Hedge Funds and 16 Best Income Stocks To Buy According to Analysts.

Page 5 of 5